title: Analysis of the arabinose-5-phosphate isomerase of Bacteroides fragilis provides insight into regulation of single-domain arabinose phosphate isomerases.
abstract: Arabinose-5-phosphate isomerases (APIs) catalyze the interconversion of d-ribulose-5-phosphate and D-arabinose-5-phosphate, the first step in the biosynthesis of 3-deoxy-D-manno-octulosonic acid (Kdo), an essential component of the lipopolysaccharide in Gram-negative bacteria. Classical APIs, such as Escherichia coli KdsD, contain a sugar isomerase domain and a tandem cystathionine beta-synthase domain. Despite substantial effort, little is known about structure-function relationships in these APIs. We recently reported an API containing only a sugar isomerase domain. This protein, c3406 from E. coli CFT073, has no known physiological function. In this study, we investigated a putative single-domain API from the anaerobic Gram-negative bacterium Bacteroides fragilis. This putative API (UniProt ID Q5LIW1) is the only protein encoded by the B. fragilis genome with significant identity to any known API, suggesting that it is responsible for lipopolysaccharide biosynthesis in B. fragilis. We tested this hypothesis by preparing recombinant Q5LIW1 protein (here referred to by the UniProt ID Q5LIW1), characterizing its API activity in vitro, and demonstrating that the gene encoding Q5LIW1 (GenBank ID YP_209877.1) was able to complement an API-deficient E. coli strain. We demonstrated that Q5LIW1 is inhibited by cytidine 5'-monophospho-3-deoxy-D-manno-2-octulosonic acid, the final product of the Kdo biosynthesis pathway, with a Ki of 1.91 μM. These results support the assertion that Q5LIW1 is the API that supports lipopolysaccharide biosynthesis in B. fragilis and is subject to feedback regulation by CMP-Kdo. The sugar isomerase domain of E. coli KdsD, lacking the two cystathionine beta-synthase domains, demonstrated API activity and was further characterized. These results suggest that Q5LIW1 may be a suitable system to study API structure-function relationships.
authors.affiliation: Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan, USA.
authors.forename: David
authors.initials: D
authors.lastname: Cech
authors.affiliation: Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan, USA.
authors.forename: Pan Fen
authors.initials: PF
authors.lastname: Wang
authors.affiliation: Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan, USA.
authors.forename: Tod P
authors.initials: TP
authors.lastname: Holler
authors.affiliation: Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan, USA rww@umich.edu.
authors.forename: Ronald W
authors.initials: RW
authors.lastname: Woodard
mesh_terms: D019747:Aldose-Ketose Isomerases / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000302:isolation & purification / Q000378:metabolism; D001089:Arabinose / Q000378:metabolism; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D001441:Bacteroides fragilis / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics; D003568:Cytidine Monophosphate / Q000031:analogs & derivatives* / Q000494:pharmacology; D004926:Escherichia coli / Q000235:genetics / Q000378:metabolism; D005816:Genetic Complementation Test; D007700:Kinetics; D008070:Lipopolysaccharides / Q000378:metabolism; D008670:Metals / Q000032:analysis; D008970:Molecular Weight; D016297:Mutagenesis, Site-Directed; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins; D013379:Substrate Specificity; D013400:Sugar Acids / Q000494:pharmacology*
chemical_list: D001426:Bacterial Proteins; D008070:Lipopolysaccharides; D008670:Metals; D011994:Recombinant Proteins; D013400:Sugar Acids; C094610:cytidine-5'-monophosphate-3-deoxy-manno-octulosonic acid; D001089:Arabinose; D019747:Aldose-Ketose Isomerases; C041486:arabinose-5-phosphate isomerase; D003568:Cytidine Monophosphate